| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/11/2002 | WO2002029045A2 Method for the production of vitamin k-dependent proteins |
| 04/11/2002 | WO2002029038A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | WO2002029036A2 Lipid metabolism enzymes |
| 04/11/2002 | WO2002029025A2 Factor vii glycoforms |
| 04/11/2002 | WO2002029022A2 Chlorophyllases |
| 04/11/2002 | WO2002029015A1 Assay for rapid detection of human activated protein c and highly specific monoclonal antibody therefor |
| 04/11/2002 | WO2002029014A2 Stem cell differentiation-inducing promoter |
| 04/11/2002 | WO2002029013A1 Culture of goblet cells |
| 04/11/2002 | WO2002029012A1 Processes for clonal growth of hepatic progenitor cells |
| 04/11/2002 | WO2002029011A2 Use of a composition with antioxidant activity for conditioning stem cells |
| 04/11/2002 | WO2002029010A2 Method for obtaining in vitro mammal islet cells and uses thereof |
| 04/11/2002 | WO2002028997A2 Methods of isolating bipotent hepatic progenitor cells |
| 04/11/2002 | WO2002028996A1 Automated bioculture and bioculture experiments system |
| 04/11/2002 | WO2002028906A2 Regulation of human sphingosine kinase-like protein |
| 04/11/2002 | WO2002028902A2 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 04/11/2002 | WO2002028897A2 Human g-protein coupled receptor and uses thereof |
| 04/11/2002 | WO2002028889A2 Haemophilus influenzae antigens and corresponding dna fragments |
| 04/11/2002 | WO2002028888A2 Mimotope of neisseria meningitides lipooligosaccharide and vaccines containing the same |
| 04/11/2002 | WO2002028878A1 Antisense modulation of smad6 expression |
| 04/11/2002 | WO2002028424A2 Kyberdrug as autovaccines with immune-regulating effects |
| 04/11/2002 | WO2002028420A2 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
| 04/11/2002 | WO2002028419A2 Chemokine mutants in the treatment of multiple sclerosis |
| 04/11/2002 | WO2002028414A1 Compositions and methods for wt1 specific immunotherapy |
| 04/11/2002 | WO2002028351A2 Recombinant mucin binding proteins from steptococcus pneumoniae |
| 04/11/2002 | WO2002028188A1 Derivation of human tumor cell lines using passage in transgenic mice having selectable markers |
| 04/11/2002 | WO2002012441A3 Cryopreservation of sperm |
| 04/11/2002 | WO2002012275A3 Lat peptides and their use in assays for identifying immunosuppressants |
| 04/11/2002 | WO2002009650A3 Methods and compositions for the repair and/or regeneration of damaged myocardium |
| 04/11/2002 | WO2002007514A3 Glycosylated vegf-b and method for increasing the amount of soluble vegf-b |
| 04/11/2002 | WO2002003911A3 Prevention and treatment of alzheimer's disease |
| 04/11/2002 | WO2002000725A3 G-protein coupled receptor org10 |
| 04/11/2002 | WO2001098513A3 Methods and means for the complementation of viral protein expression in stable cell lines |
| 04/11/2002 | WO2001092581A8 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 04/11/2002 | WO2001092308A3 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 04/11/2002 | WO2001090339A3 Methods and compositions to activate genes in cells |
| 04/11/2002 | WO2001085935A3 Endothelial differentiation gene 6-like g protein coupled receptor |
| 04/11/2002 | WO2001083768A3 Serine-threonine kinase |
| 04/11/2002 | WO2001082963A3 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 04/11/2002 | WO2001082828A3 Tissue engineered testicular prosthesis and use thereof |
| 04/11/2002 | WO2001080865A3 Joint repair using mesenchymal stem cells |
| 04/11/2002 | WO2001077148A3 Human lipid binding protein 1 |
| 04/11/2002 | WO2001074856A3 Wnt-7b-like polypeptides and nucleic acids encoding same |
| 04/11/2002 | WO2001072780A3 Polynucleotides for diagnosing mammary gland cancer |
| 04/11/2002 | WO2001070989A3 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins |
| 04/11/2002 | WO2001070174A3 Vegf-modulated genes and methods employing them |
| 04/11/2002 | WO2001068833A3 Recombinant hhv8 dna |
| 04/11/2002 | WO2001065262A3 Reagents and methods useful for detecting diseases of the breast |
| 04/11/2002 | WO2001060844A3 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 04/11/2002 | WO2001058477A3 Immunization of an individual against carcinoma and the preliminary stages thereof |
| 04/11/2002 | WO2001053348A3 Human polypeptides related to the vanilloid and trp families of cation channel proteins and nucleic acids encoding them |
| 04/11/2002 | WO2001036616A3 Acid nucleic construct bearing a system regulating the expression of a gene |
| 04/11/2002 | WO2000055373A3 Methods of screening for macrophage development modulators |
| 04/11/2002 | WO2000049164A9 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants |
| 04/11/2002 | WO2000047762A9 Enriched central nervous system cell populations |
| 04/11/2002 | WO2000036103A9 Cytokine receptor chain |
| 04/11/2002 | WO2000032181A9 Method for reducing free-radical induced injury |
| 04/11/2002 | WO2000028008A9 Modified ribulose 1,5-bisphosphate carboxylase/oxygenase |
| 04/11/2002 | US20020042932 Recombinant vector containing prokaryotic gene from bacillus or intestinal bacteria including ubiquitin promoter that targets cytosol or plastid of host plant, enhancing photosynthetic efficiency |
| 04/11/2002 | US20020042927 Meiosis activating sterol augments implantation rate |
| 04/11/2002 | US20020042387 Administering nucleic acid as antiinflammatory agent |
| 04/11/2002 | US20020042386 Genetic engineering |
| 04/11/2002 | US20020042385 Cloning of a novel 7TM receptor AXOR-2 |
| 04/11/2002 | US20020042373 Administering thrombin receptor antagonist; bone disorders |
| 04/11/2002 | US20020042367 Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders |
| 04/11/2002 | US20020042364 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 04/11/2002 | US20020042149 Analyzing preferential particles in bodily fluid; obtain sample, incubate with binding particles, detect bound particles |
| 04/11/2002 | US20020042138 Inducing globin gene expression in cells; obtain cells, incubate with preferential nucleotide sequences, monitor cells for amplified globin expression |
| 04/11/2002 | US20020042137 System for generating recombinant viruses |
| 04/11/2002 | US20020042136 Retroviral vectors comprising an enhanced 3' transcription termination structure |
| 04/11/2002 | US20020042133 Immortalised cell line derived from normal human skin tissues |
| 04/11/2002 | US20020042132 Mammalian gamete and embryo culture media supplement and method of using same |
| 04/11/2002 | US20020042130 Propagating preferential aggregations; obtain aggregation, incubate with buffy coat cells, propagate, recover genetically engineered cells |
| 04/11/2002 | US20020042129 Keratinocytes and melanocytes; without any feeder cells; maintain the ability to express keratins, cytochromes, as well as other differentiation proteins |
| 04/11/2002 | US20020042128 Electroprocessed fibrin-based matrices and tissues |
| 04/11/2002 | US20020042127 Genetically engineered aggregation for use in the treatment of cancer |
| 04/11/2002 | US20020042114 Novel human protein kinases |
| 04/11/2002 | US20020042110 Novel carbonyl reductase, method for producing said enzyme, DNA encoding said enzyme, and method for producing alcohol using said enzyme |
| 04/11/2002 | US20020042101 Nucleotide sequences which code enzymatic polypeptide for use in the treatment of cancer, restenosis and diabetic neuropathy |
| 04/11/2002 | US20020042096 Nucleic acids, proteins, and antibodies |
| 04/11/2002 | US20020042093 Polypeptide; for use in diagnosis, treatment or prevention of thyroid tumors and defects |
| 04/11/2002 | US20020042089 Interleukin-5 specific recombinant antibodies |
| 04/11/2002 | US20020042045 METHODS FOR THE DETECTION OF HTLV-II ANTIBODIES EMPLOYIING NOVEL HTLV-II nra ENVELOPE PEPTIDES |
| 04/11/2002 | US20020042043 Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity |
| 04/11/2002 | US20020042042 Preventing tissue damage due to freezing; prepare preservation mix with freeze resistant particles, induce vitrification, mix with viable cells and cool cells |
| 04/11/2002 | US20020041900 Chondrocyte cultures and fractions therefrom |
| 04/11/2002 | US20020041876 Modulation of angiogenesis |
| 04/11/2002 | US20020041869 Methods for treating cells |
| 04/11/2002 | US20020041868 Cell fusions and methods of making and using the same |
| 04/11/2002 | DE10043481A1 Humaner Antikörper gegen Endoglin (CD105) und seine Verwendung Human antibodies against endoglin (CD105) and its use |
| 04/11/2002 | CA2425269A1 G-protein coupled receptors |
| 04/11/2002 | CA2425169A1 Hematopoietin receptors hpr1 and hpr2 |
| 04/11/2002 | CA2425126A1 Lipid metabolism enzymes |
| 04/11/2002 | CA2425092A1 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
| 04/11/2002 | CA2425072A1 Wt1 fusion polypeptides and methods for wt1 immunotherapy |
| 04/11/2002 | CA2424834A1 Nogo receptor homologs |
| 04/11/2002 | CA2424817A1 Cells having a spectral signature, and methods of preparation and use thereof |
| 04/11/2002 | CA2424781A1 Methods of isolating bipotent hepatic progenitor cells |
| 04/11/2002 | CA2424779A1 Processes for clonal growth of hepatic progenitor cells |
| 04/11/2002 | CA2424738A1 Retroviral vectors containing internal ribosomal entry sites |
| 04/11/2002 | CA2424543A1 Component for vaccine |